Qiming Medical - B (Stock Code: 2500) announced that it will hold a board of directors meeting on August 30, 2024 (Friday) to review and approve the company and its subsidiaries' mid-year performance ending on June 30, 2024, as well as its release. The meeting will also consider whether to recommend the distribution of interim dividends and handle other matters. The meeting will be chaired by executive director Mr. Lin Haosheng and was notified on August 20, 2024. The company's current executive directors include Mr. Lin Haosheng, Mr. Ma Lijiao, and Ms. Liu Meirong. The non-executive directors are Mr. Zhang Ao and Mr. Wang Wei, and the independent non-executive directors are Mr. Hu Dingxu and Mr. Sun Zhiwei.

Qiming Medical - B (Stock Code: 2500) announced that it will hold a board of directors meeting on August 30, 2024 (Friday) to review and approve the company and its subsidiaries' mid-year performance ending on June 30, 2024, as well as its release. The meeting will also consider whether to recommend the distribution of interim dividends and handle other matters. The meeting will be chaired by executive director Mr. Lin Haosheng and was notified on August 20, 2024. The company's current executive directors include Mr. Lin Haosheng, Mr. Ma Lijiao, and Ms. Liu Meirong. The non-executive directors are Mr. Zhang Ao and Mr. Wang Wei, and the independent non-executive directors are Mr. Hu Dingxu and Mr. Sun Zhiwei.